Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-22

Clinical Trial Update: Assessment of Postoperative Pain After Using Two Formulations of Calcium Hydroxide Intracanal Medication . [Phase 4]

View source ↗

Summary

Clinical trial update evaluating postoperative pain after two formulations of calcium hydroxide intracanal medication in necrotic pulp with symptomatic apical p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • calcium hydroxide intracanal medication (two formulations) (calcium hydroxide intracanal medication)

Snippet

Sponsor: Suez Canal University | Conditions: Necrotic Pulp With Symptomatic Apical Periodontitis | Phase 4 | Status: UNKNOWN